Johnson&Johnson

Pharmaceutical giant, Johnson & Johnson, stumbled again with a recall of “more than 13 million packages of Rolaids heartburn products following consumer complaints of foreign materials in the product, including metal and wood particles,” Fox Business reports.

Fox explains that this “Rolaids recall adds to the growing list of over-the-counter products recalled by J&J over the past year, which have hurt its sales and tarnished its once-sterling reputation for product quality.”

According to Bloomberg News, a judicial panel recently decided that all of the pretrial proceedings in federal lawsuits against pharmaceutical giant, Johnson & Johnson, over their recalled hip-replacement systems will be overseen in Ohio by one federal judge. 

The news source reports that U.S. District Judge David A. Katz will “supervise evidence-gathering efforts in cases over the ASR XL Acetabular System, which J&J’s DePuy Orthopaedics unit recalled on Aug. 26 after the implants stopped functioning properly.”

MSNBC news reports that things worsened on Wednesday for the pharmaceutical giant, Johnson & Johnson, after they recalled 12 million bottles of their over-the-counter medicine, Mylanta, and nearly 85,000 bottles of AlternaGel liquid antacid.

The news source explains the company initiated the recalls because “the presence of small amounts of alcohol from flavoring agents was not noted on product packaging.”